Skip to content

Measuring Intraabdominal Pressure, Lactic Acid, and Urine Output

Measuring Intraabdominal Pressure, Lactic Acid, and Urine Output in Obese Individuals Undergoing Laparoscopic Inguinal Hernia Repair

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05070572
Enrollment
21
Registered
2021-10-07
Start date
2021-01-01
Completion date
2023-04-30
Last updated
2026-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inguinal Hernia, Intra-Abdominal Hypertension

Brief summary

This study serves as a pilot study with the intention to to measure intraabdominal pressure, lactic acid, and urine output in obese individuals undergoing laparoscopic inguinal hernia repair. By measuring these values, the investigators aim to look for correlations between metrics and determine an accurate and precise measurement of IAP during laparoscopic hernia surgery using the Accuryn Monitoring System. By obtaining accurate and precise measurements of IAP during surgery the investigators will be to compare measurements to previous IAP data obtained during daily activities and strenuous movements and any associations with inguinal hernia recurrence.

Interventions

Utilization of the Accuryn Monitoring System to measure intraabdominal pressure and urine output during laparoscopic inguinal hernia repair surgery.

Sponsors

Antonios Likourezos
Lead SponsorOTHER
Potrero Medical
CollaboratorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years

Inclusion criteria

* Obese with BMI \> 30 * Diagnosis of inguinal hernia * Qualify for laparoscopic inguinal hernia repair

Exclusion criteria

* Previous bowel resections resulting in short bowel * Extensive abdominal scarring * BMI \< 30 * Fail to qualify for laparoscopic inguinal hernia repair

Design outcomes

Primary

MeasureTime frameDescription
Intraabdominal Pressure2 hoursMaximum IAP levels during surgery

Countries

United States

Baseline characteristics

Characteristic
Age, Continuous58 years
STANDARD_DEVIATION 16.5
Region of Enrollment
United States
21 participants
Sex: Female, Male
Female
0 Participants
Sex: Female, Male
Male
21 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 21
other
Total, other adverse events
0 / 21
serious
Total, serious adverse events
0 / 21

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 30, 2026